Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers
- DOI
- 10.1080/14796694.2025.2569553
- Published
- 2025-10-17
- Container
- Future Oncology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2025.2569553,
title = {Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers},
author = {Sara Hurvitz and Matteo Simonelli and Ramón Yarza and David Berz and Shigehisa Kitano and Gianluca Del Conte and Daniel Acosta Eyzaguirre and Bernard Gaston Doger de Speville Uribe and Daniela Maier and Damijan Erzen and Sila Aykut Yazgili and Giuseppe Curigliano and Ting Deng and Min Yan and Qingyuan Zhang and Xian Wang and Izuma Nakayama and Kohei Shitara},
year = {2025},
journal = {Future Oncology},
doi = {10.1080/14796694.2025.2569553},
url = {https://doi.org/10.1080/14796694.2025.2569553}
}RIS
TY - JOUR TI - Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers AU - Sara Hurvitz AU - Matteo Simonelli AU - Ramón Yarza AU - David Berz AU - Shigehisa Kitano AU - Gianluca Del Conte AU - Daniel Acosta Eyzaguirre AU - Bernard Gaston Doger de Speville Uribe AU - Daniela Maier AU - Damijan Erzen AU - Sila Aykut Yazgili AU - Giuseppe Curigliano AU - Ting Deng AU - Min Yan AU - Qingyuan Zhang AU - Xian Wang AU - Izuma Nakayama AU - Kohei Shitara PY - 2025 JO - Future Oncology DO - 10.1080/14796694.2025.2569553 UR - https://doi.org/10.1080/14796694.2025.2569553 ER -
APA
Hurvitz, S., Simonelli, M., Yarza, R., Berz, D., Kitano, S., Conte, G. D., Eyzaguirre, D. A., Uribe, B. G. D. D. S., Maier, D., Erzen, D., Yazgili, S. A., Curigliano, G., Deng, T., Yan, M., Zhang, Q., Wang, X., Nakayama, I., & Shitara, K. (2025). Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers. Future Oncology. https://doi.org/10.1080/14796694.2025.2569553
Source records
- crossref · retrieved 2026-09-26T09:24:01.052Z